NeuroMetrix Announces WellMed Medical Management’s Integration of NC-stat® DPNCheck™ Into Their Patient Evaluation Program WALTHAM, Mass. --(BUSINESS WIRE)--May. 15, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , a medical device company focused on the diagnosis and treatment of the
NeuroMetrix, Inc. Announces Conference Call to Discuss American Diabetes Association 72nd Scientific Sessions and Other Business Activities WALTHAM, Mass. --(BUSINESS WIRE)--Jun. 18, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO), www.neurometrix.com , today said it will host a conference call at 10:00
NeuroMetrix, Inc. Announces Date for 2012 Second Quarter Financial Results Conference Call WALTHAM, Mass. --(BUSINESS WIRE)--Jul. 18, 2012-- NeuroMetrix, Inc. (Nasdaq: NURO) today said it plans to issue its 2012 second quarter financial results before the opening of the market on July 26, 2012 .